You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Harvard Business School
Moodys
McKesson
Boehringer Ingelheim

Last Updated: September 22, 2020

DrugPatentWatch Database Preview

Patent: 8,119,183

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,119,183
Title:Method of doping surfaces
Abstract: Disclosed herein are methods of treating an article surface. The method comprises removing a metal oxide surface from the metal substrate to expose a metal surface; and delivering particles comprising a dopant from at least one fluid jet to the metal surface to impregnate the surface of the article with the dopant. The method also comprises delivering substantially simultaneously a first set of particles comprising a dopant and a second set of particles comprising an abrasive from at least one fluid jet to a surface of an article to impregnate the surface of the article with the dopant.
Inventor(s): O\'Donoghue; John Gerard (Dungarvan, IE), Haverty; Donncha (Co. Limerick, IE)
Assignee: EnBIO Limited (Carrigtwohill, Co. Cork, IE)
Application Number:11/853,764
Patent Claims:see list of patent claims

Details for Patent 8,119,183

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10   Start Trial EnBIO Limited (Carrigtwohill, Co. Cork, IE) 2027-04-06 RX search
Organon Usa Inc. TICE BCG bacillus calmette-guerin POWDER, FOR SUSPENSION 102821 1 1990-08-24   Start Trial EnBIO Limited (Carrigtwohill, Co. Cork, IE) 2027-04-06 search
Chiron PROLEUKIN aldesleukin VIAL 103293 001 1992-05-05   Start Trial EnBIO Limited (Carrigtwohill, Co. Cork, IE) 2027-04-06 RX search
Amgen NEUPOGEN filgrastim VIAL 103353 001 1991-02-20   Start Trial EnBIO Limited (Carrigtwohill, Co. Cork, IE) 2027-04-06 RX search
Amgen NEUPOGEN filgrastim VIAL 103353 002 1991-02-20   Start Trial EnBIO Limited (Carrigtwohill, Co. Cork, IE) 2027-04-06 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Harvard Business School
Medtronic
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.